IIL - results, page-5

All that IIL can comment on is the numbers that finish the trial that requeat access to the compassionate use program....otherwise IIL will release study results once they receive this information from those collating/tabulating the sata from the study.....this is the nature of a double blind scientific study....IIL will not know which patients are receiving placebo or MS416, nor will the patients, simply those requesting access to MS416 (compassionate use program) after they have finished their 12 months,

and for every seller, there have been buyers moping up these shares but why would buyers offer a higher price to ourchase shares if their orders keep being filled at liwer prices....whether this is panic selling/frustrated traders or deliberate forcing down of the price (accumulators triggering stops, hoping to buy more than they are selling),

Kind regards, SEAH.